Sinopharm applies for vaccine market approval
2020-11-25 14:29
A staff member displays a sample of the COVID inactivated vaccine at a vaccine production plant of China National Pharmaceutical Group Co Ltd Sinopharm in Beijing, capital of China, April , . PhotoXinhua    Leading COVID vaccine developer Sinopharm has submitted a market approval application to the top market regulator, according to media reports.